{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [
    [
      "ATP",
      "P2X7 receptor",
      "depression",
      "inflammation",
      "mood disorders",
      "stress"
    ]
  ],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "30093269",
  "DateCompleted": {
    "Year": "2019",
    "Month": "05",
    "Day": "01"
  },
  "DateRevised": {
    "Year": "2019",
    "Month": "05",
    "Day": "01"
  },
  "Article": {
    "ArticleDate": [
      {
        "Year": "2018",
        "Month": "08",
        "Day": "06"
      }
    ],
    "Language": [
      "eng"
    ],
    "ELocationID": [
      "10.1016/j.molmed.2018.07.005",
      "S1471-4914(18)30144-8"
    ],
    "Journal": {
      "ISSN": "1471-499X",
      "JournalIssue": {
        "Volume": "24",
        "Issue": "9",
        "PubDate": {
          "Year": "2018",
          "Month": "Sep"
        }
      },
      "Title": "Trends in molecular medicine",
      "ISOAbbreviation": "Trends Mol Med"
    },
    "ArticleTitle": "P2X7 Receptor: A Potential Therapeutic Target for Depression?",
    "Pagination": {
      "StartPage": "736",
      "EndPage": "747",
      "MedlinePgn": "736-747"
    },
    "Abstract": {
      "AbstractText": [
        "Depression is a prime contributor to global disease burden with 300 million affected patients worldwide. The persistent lack of progress with regards to pharmacotherapy stands in stark contrast to the pandemic magnitude of the disease. Alterations of inflammatory pathways in depressed patients, including altered circulating pro-inflammatory cytokines, have been put forward as a potential pathophysiological mechanism. The P2X7 receptor (P2X7R) plays an important role regulating the release of interleukin-1\u03b2 and other cytokines. Comprehensive investigation of the P2X7R Gln460Arg missense mutation (rs2230912), which has been associated with major depression and bipolar disorder, has substantially contributed to validate P2X7R as a potential genetic risk factor. We propose that P2X7R is a putative target with good prospects for therapeutic intervention in depressive disorders."
      ],
      "CopyrightInformation": "Copyright \u00a9 2018 Elsevier Ltd. All rights reserved."
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Molecular Neurogenetics, Department of Stress Neurobiology and Neurogenetics, Max Planck Institute of Psychiatry, Kraepelinstr. 2-10, 80804 Munich, Germany. Electronic address: deussing@psych.mpg.de."
          }
        ],
        "LastName": "Deussing",
        "ForeName": "Jan M",
        "Initials": "JM"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Instituto de Investigaci\u00f3n en Biomedicina de Buenos Aires (IBioBA)-CONICET-Partner Institute of the Max Planck Society; and University of Buenos Aires, Argentina, Godoy Cruz 2390, C1425FQD Buenos Aires, Argentina."
          }
        ],
        "LastName": "Arzt",
        "ForeName": "Eduardo",
        "Initials": "E"
      }
    ],
    "PublicationTypeList": [
      "Journal Article",
      "Research Support, Non-U.S. Gov't",
      "Review"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "England",
    "MedlineTA": "Trends Mol Med",
    "NlmUniqueID": "100966035",
    "ISSNLinking": "1471-4914"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Cytokines"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Receptors, Purinergic P2X7"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [],
      "DescriptorName": "Animals"
    },
    {
      "QualifierName": [
        "analysis",
        "immunology"
      ],
      "DescriptorName": "Cytokines"
    },
    {
      "QualifierName": [
        "complications",
        "drug therapy",
        "genetics",
        "immunology"
      ],
      "DescriptorName": "Depression"
    },
    {
      "QualifierName": [
        "complications",
        "drug therapy",
        "genetics",
        "immunology"
      ],
      "DescriptorName": "Depressive Disorder"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Drug Discovery"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [
        "complications",
        "drug therapy",
        "genetics",
        "immunology"
      ],
      "DescriptorName": "Inflammation"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Molecular Targeted Therapy"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Mutation, Missense"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Polymorphism, Single Nucleotide"
    },
    {
      "QualifierName": [
        "analysis",
        "genetics",
        "immunology"
      ],
      "DescriptorName": "Receptors, Purinergic P2X7"
    }
  ]
}